A seizure emergency does not leave much room for improvisation. The person having the seizure may be unable to speak or swallow safely. A caregiver may be frightened, unsure when to act, or trying to remember instructions learned months earlier. The difference between having a rescue prescription and having a usable rescue plan becomes obvious in those minutes.
Seizure rescue medications are fast-acting treatments used in specific situations, such as a recognizable seizure cluster or an episode that is lasting longer than the person’s usual seizures. They do not replace daily antiseizure medication, and they do not eliminate the need for emergency care when warning signs are present. Their value depends on something less dramatic but just as important: knowing exactly which event should trigger treatment, who will give it, whether a second dose is allowed, and when to call 911.
The medication matters. The written plan makes it usable.
In this article
What Rescue Medication Does
Most outpatient seizure rescue medications are benzodiazepines, commonly diazepam or midazolam. They are designed to act quickly enough to interrupt an acute pattern of increased seizure activity. The Epilepsy Foundation describes rescue therapy as as-needed treatment intended to stop seizures quickly and reduce the chance that the situation develops into an emergency.
That does not mean every seizure should be treated with a rescue medication. Many seizures stop on their own within the person’s established pattern. FDA-approved outpatient products are generally labeled for intermittent, stereotypic episodes of frequent seizure activity—often called seizure clusters or acute repetitive seizures—that are distinct from the patient’s usual pattern. The prescriber and patient need to translate that formal language into recognizable real-life instructions.
A rescue plan may also address a prolonged seizure, but the trigger should come from the treating clinician rather than from a generic internet rule. One person’s instruction may be based on seizure duration; another person’s may be based on the number of seizures, reduced recovery between events, or an unmistakable cluster pattern.
Who May Need a Rescue Plan
Not everyone with epilepsy needs an outpatient rescue medication. It is most relevant when a person has experienced seizure clusters, unusually prolonged seizures, status epilepticus, or another predictable pattern that can escalate. It may also deserve discussion when medication changes, illness, travel, sleep disruption, or missed doses have previously increased risk.
People with drug-resistant epilepsy are an obvious group to consider, but diagnosis alone does not determine the plan. A person whose seizures are frequent but brief and self-limited may need different instructions from someone whose events tend to cluster or continue. The useful question is not simply, “Do I have epilepsy?” It is, “Do I have a recognizable seizure pattern for which early treatment could change what happens next?”
A rescue prescription should be paired with training for anyone expected to use it. That may include a spouse, parent, adult child, roommate, school nurse, coworker, caregiver, or program staff member. A device that stays in a drawer because no one is confident using it is not much of an emergency system.
Current Outpatient Options in the United States
The available routes differ in approved ages, dose selection, repeat-dose timing, privacy, ease of administration, and cost. The table below is an orientation, not a dosing guide. The prescription label and individualized seizure action plan control.
| Medication and route | Current FDA-labeled population | Practical point |
|---|---|---|
| Diazepam nasal spray (Valtoco) | Age 2 and older | Weight- and age-based dosing; some doses require one device and others require two. |
| Midazolam nasal spray (Nayzilam) | Age 12 and older | Single-dose device; the labeled repeat-dose interval differs from diazepam nasal spray. |
| Diazepam rectal gel (Diastat and generics) | Age 2 and older | Long-established option that may remain useful when another route is unsuitable. |
| Diazepam buccal film (Libervant) | Ages 2 through 5 | Applied inside the cheek; currently approved only for this pediatric age range. |
The current FDA label for diazepam nasal spray covers patients age 2 and older. The midazolam nasal-spray label covers patients age 12 and older. Diazepam rectal gel is labeled for age 2 and older, while diazepam buccal film is approved for children ages 2 through 5.
Clinicians also sometimes prescribe other benzodiazepine formulations off label for out-of-hospital rescue use. Oral, buccal, or sublingual administration may be considered in selected circumstances, particularly when the person remains alert and can follow directions. Nothing should be placed in the mouth of someone who is convulsing, unresponsive, or unable to swallow safely. The route should be prescribed and practiced in advance rather than improvised during a seizure.
Why the Instructions Must Be Specific
The products are not interchangeable instruction sets. Under current labeling, a second dose of midazolam nasal spray may be given after 10 minutes when needed, while a second dose of diazepam nasal spray may be given at least four hours after the first. Both limit treatment to no more than two doses for one episode, but their recommended frequency limits also differ.
Those differences are exactly why a caregiver should not rely on memory from someone else’s prescription or on a general article. A written plan should name the product, dose, route, event that triggers treatment, earliest permitted repeat dose, maximum doses, and the conditions that rule out another dose. If the medication changes, the plan must change with it.
The plan should describe the treatable pattern in ordinary language. “Use for seizure cluster” may be technically correct and practically useless if the caregiver does not know what the person’s cluster looks like. Better instructions identify the observable pattern: how many seizures, over what period, what recovery normally looks like, and which change signals escalation.
Sedation, Breathing, and Medication Safety
Rescue benzodiazepines can cause sleepiness, impaired coordination, and respiratory depression. The danger is greater when they are combined with opioids, alcohol, or other central nervous system depressants. Current FDA labeling carries boxed warnings about the risks of combining benzodiazepines with opioids and about abuse, misuse, dependence, and withdrawal.
The seizure itself can also affect breathing and awareness, which makes observation after treatment essential. Stay with the person, note the time the medication was given, watch breathing and skin color, and follow the written instructions. The Valtoco and Nayzilam labels specifically caution against giving a second dose when there is concerning breathing difficulty or unusual excessive sedation.
Storage and access matter as much as the prescription. Keep the medication where the trained person can reach it, check expiration dates, protect it from conditions outside the labeled storage range, and replace used or expired doses promptly. If rescue medication is carried between home, work, school, church, travel, or a day program, decide whether more than one supply is needed rather than assuming the same package will always be nearby.
When Rescue Medication Does Not Replace 911
A rescue medication is part of emergency preparation, not permission to ignore an emergency. The CDC’s seizure first-aid guidance says to call 911 when a seizure lasts longer than five minutes, another seizure starts soon afterward, the person has trouble breathing or waking, the person is injured, or the seizure occurs in water. Emergency help is also warranted for a first seizure, pregnancy, or diabetes with loss of consciousness.
An individualized action plan may modify the response for someone with a known history and a prescribed rescue pathway, but it should never leave the caregiver guessing. The plan needs an explicit emergency line: call 911 if the medication does not work within the prescribed time, breathing or color is concerning, recovery is not occurring as expected, the episode is different from the usual pattern, an injury occurred, or the caregiver is alarmed by the situation.
Basic first aid continues while help is coming: protect the person from injury, ease them to the ground if needed, place them on their side when possible, loosen restrictive clothing around the neck, and time the seizure. Do not restrain them, put anything in their mouth, or offer food or water until they are fully alert. For more detail, see Status Epilepticus: What It Is, Warning Signs & What to Do.
How to Build a Plan People Can Actually Follow
The Epilepsy Foundation provides fillable seizure action plans, including a general plan and an acute seizure action plan. A useful plan should answer the questions that become difficult under pressure:
- What do the person’s usual seizures look like?
- Which specific pattern should trigger rescue medication?
- What medication, dose, and route should be used?
- Who is trained and authorized to administer it?
- When may a second dose be given, and when must it not be given?
- What should be monitored after treatment?
- Exactly when should 911 be called?
- Who should be contacted after the episode?
- Where are the medication and backup copy of the plan kept?
Review the plan with the prescribing clinician and the people expected to carry it out. Ask them to demonstrate the device using training materials or a trainer when available. Revisit the plan at least yearly and whenever the seizure pattern, medication, dose, caregiver, school, workplace, or living arrangement changes.
It is also worth bringing the plan to neurology visits rather than discussing rescue treatment as an abstract possibility. The questions in Questions to Ask Your Neurologist can help frame the broader conversation about treatment failure, safety, side effects, and next steps.
Bottom Line
Rescue medication can give patients and caregivers a way to act early when a familiar seizure pattern begins to escalate. But the prescription is only one part of the system. The real preparation is a specific, current, rehearsed plan that identifies the treatable event, gives product-specific instructions, accounts for breathing and sedation risks, and makes the emergency threshold unmistakable.
If a person has clusters, prolonged seizures, a history of status epilepticus, or episodes that repeatedly create uncertainty about when to intervene, that is a reasonable reason to ask the treating clinician whether a rescue medication and written seizure action plan belong in the care strategy.
Sources & Further Reading
- Epilepsy Foundation: Seizure Rescue Therapies
- Epilepsy Foundation: Seizure Action Plans
- CDC: First Aid for Seizures
- FDA Prescribing Information: Valtoco (diazepam nasal spray)
- FDA Prescribing Information: Nayzilam (midazolam nasal spray)
- FDA Prescribing Information: Diastat (diazepam rectal gel)
- DailyMed: Libervant (diazepam buccal film)
Disclaimer
Content on Real David Julian is provided for educational and informational purposes and may include research-based discussion, personal experience, and opinion. It is not medical advice and is not a substitute for individualized care from a qualified healthcare professional. Always discuss your specific health needs, diagnoses, medications, supplements, treatments, or major health decisions with an appropriate healthcare professional. See the full Disclaimer for additional information.